PRESS RELEASE published on 08/05/2024 at 10:32, 1 year 4 months ago Medios expands „Advanced Therapies“ field and appoints Dr. Andreas Schmiede as Vice President Medios AG strengthens activities in Advanced Therapies field, appoints Dr. Andreas Schmiede as Vice President. Focus on personalized medicine innovations and patient access to cutting-edge therapies Medios AG Advanced Therapies Personalized Medicine Dr. Andreas Schmiede Pharmaceutical Innovations
BRIEF published on 07/01/2024 at 09:37, 1 year 5 months ago « Hauptstadtkongress 2024 » : Medios organise un symposium sur la « sécurité d'approvisionnement » Medios AG Pharmacie Spécialisée Congrès De La Hauptstadt 2024 Système De Soins De Santé Sécurité D'approvisionnement
BRIEF published on 07/01/2024 at 09:37, 1 year 5 months ago “Hauptstadtkongress 2024”: Medios Hosts Symposium on 'Security of Supply' Healthcare System Medios AG Specialty Pharma Hauptstadtkongress 2024 Security Of Supply
PRESS RELEASE published on 07/01/2024 at 09:32, 1 year 5 months ago “Hauptstadtkongress 2024”: Medios hosts symposium on 'Security of supply” Medios AG participated in 'Hauptstadtkongress 2024', focusing on 'Security of supply'. Experts discussed challenges in patient care and the importance of cooperation in Specialty Pharma sector Healthcare System Medios AG Specialty Pharma Hauptstadtkongress 2024 Security Of Supply
BRIEF published on 06/20/2024 at 10:07, 1 year 5 months ago Transfert réussi des actions Medios AG à Luxempart SA Investissement Medios AG Vente D'actions Pharmacie Spécialisée Luxempart SA
BRIEF published on 06/20/2024 at 10:07, 1 year 5 months ago Successful Transfer of Medios AG Shares to Luxempart S.A. Investment Medios AG Share Sale Specialty Pharma Luxempart S.A.
PRESS RELEASE published on 06/20/2024 at 10:02, 1 year 5 months ago Medios AG: Successful sale of shares from Company founder Manfred Schneider to Luxempart S.A. Medios AG founder Manfred Schneider sells 14.9% of shares to Luxempart S.A., a Luxembourg investment company, marking a turning point in Medios' growth strategy Investment Medios AG Specialty Pharma Luxempart S.A. Manfred Schneider
BRIEF published on 06/07/2024 at 10:33, 1 year 5 months ago Hauck & Aufhäuser lance la couverture de Medios AG avec une recommandation d'achat et un objectif de prix de 23,00 € Medios AG Recommandation D'achat Pharmacie Spécialisée Hauck & Aufhäuser Objectif De Prix 23,00 €
BRIEF published on 06/07/2024 at 10:33, 1 year 5 months ago Hauck & Aufhäuser Initiates Coverage of Medios AG with Buy Recommendation and €23.00 Price Target Buy Recommendation Medios AG Specialty Pharma Hauck & Aufhäuser Price Target €23.00
PRESS RELEASE published on 06/07/2024 at 10:28, 1 year 5 months ago Hauck & Aufhäuser starts coverage of Medios AG with buy recommendation and price target of €23.00 Hauck & Aufhäuser initiates coverage of Medios AG with buy recommendation and €23.00 price target, a 55% upside potential from Xetra closing price on June 5, 2024. Medios AG, a leading Specialty Pharma provider in Europe, aims at expanding innovative therapies Buy Recommendation Medios AG Price Target Specialty Pharma Hauck & Aufhäuser
Published on 12/05/2025 at 02:35, 10 hours 37 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 12 hours 12 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 14 hours 7 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 14 hours 12 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 13:00, 12 minutes ago Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 12 minutes ago Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 1 hour 7 minutes ago Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 1 hour 12 minutes ago CGTN:Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 1 hour 12 minutes ago Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 08:45, 4 hours 27 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 4 hours 27 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 4 hours 30 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 18 hours 57 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 19 hours 12 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025